EPISODE · May 15, 2026 · 5 MIN
今天3分钟我们来聊聊乳腺癌肝转移后重生？NK细胞疗法揭秘
from 源于细胞BioInsid的个人播客
一位乳腺癌患者在经历手术、化疗后仍出现肝转移，生存期仅剩数月。但通过曲妥珠单抗联合NK细胞免疫疗法，两个多月肝转移就缩小，至今病灶持续缓解。NK细胞是免疫系统的“特种兵”，无需提前识别肿瘤特征就能直接杀伤癌细胞，为癌症治疗带来新希望。参考文献：McMaster University，NK细胞长期冻存研究，Journal of Immunology病例来源：患者入组NK细胞免疫疗法联合曲妥珠单抗及紫杉醇方案临床试验曲妥珠单抗（Herceptin）Her2阳性乳腺癌适应症数据前往小宇宙评论区与主播互动
Embed this episode
Ready to play
今天3分钟我们来聊聊乳腺癌肝转移后重生？NK细胞疗法揭秘
0:00
5:02
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
Frequently Asked Questions
How long is this episode of 源于细胞BioInsid的个人播客?
This episode is 5 minutes long.
When was this 源于细胞BioInsid的个人播客 episode published?
This episode was published on May 15, 2026.
Can I download this 源于细胞BioInsid的个人播客 episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!